Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
തുറക്കുക
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
1,093.811,096.521,100.221,091.51
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
608.77608.77612.97608.77
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
1,254.811,253.011,253.871,226.33
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
1,761.111,764.271,766.881,744.71
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
642.58644.87648.48640.18
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
851.13855.66858.75845.56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
217.98217.98218.65216.88
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
3,211.833,227.213,268.383,226.55
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
948.98948.58957.83941.97
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
1,474.521,479.031,481.041,466.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
2,392.122,396.952,421.222,382.32
MDGEF:OTCMKTS
MediGene AG
$0.10
0.00%
(0.00) 1D
മേയ് 14, ജിഎംടി-4 3:57:02 PM  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDGEF...
Mkt. cap
൩൧൨.൭൬K
Volume
൦.൦൦
52-wk high
$2.59
52-wk low
$2.59
Shares outstanding
൧൪.൮൯M
No. of employees
൮൭
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
11 മിനിറ്റ് മുമ്പ്
Latest News In AI Chips - Revolutionizing Fleet Charging with Nexus Megawatt System
TheStreet Pro
TheStreet Pro
·
12 മിനിറ്റ് മുമ്പ്
An Extended Tape Meets a Vulnerable Market
Seeking Alpha
Seeking Alpha
·
12 മിനിറ്റ് മുമ്പ്
The Curious Case Of Inflation Genie (NYSEARCA:XLK)
TipRanks
TipRanks
·
16 മിനിറ്റ് മുമ്പ്
Wilmar Extends ESG Leadership with Fifth Year in Dow Jones Best-in-Class World Index
പ്രൊഫൈൽ
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
About MediGene AG
CEOഡൊളോരിസ് ജെ. ഷെൻഡൽ
Employees87
Founded1994
HeadquartersPlanegg, ബവേറിയ, ജർമ്മനി
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2023 സെപ്റ്റം
2023 ഡിസം
2024 മാർ
2024 ജൂൺ
Revenue
-
-
2.24M
1.46M
Cost of goods sold
-
-
386.50K
333.00K
Cost of revenue
-
-
386.50K
333.00K
Research and development expenses
-
-
3.14M
3.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
2.03M
2.09M
Operating expense
-
-
5.17M
5.22M
Total operating expenses
-
-
5.56M
5.55M
Operating income
-
-
-3.32M
-4.10M
Other non operating income
-
-
-5.00K
-6.00K
EBT including unusual items
-
-
-3.36M
-4.08M
EBT excluding unusual items
-
-
-3.36M
-4.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-3.00K
-2.00K
Net income
-
-
-3.36M
-4.08M
Net profit margin
-
-
-150.27%
-280.10%
Earnings per share
-
-
-
-
Interest and investment income
-
-
55.50K
110.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
55.50K
110.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-2.97M
-3.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more